Plain-English translation of NCT07331935 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Oral leukoplakia is a condition where white patches develop inside the mouth. These patches can sometimes turn into cancer over time. This trial is testing two topical gels—Coenzyme Q10 and Curcumin—which are natural antioxidants believed to help shrink these patches and prevent them from becoming more serious.
Doctors need better treatment options for mouth white patches that don't require surgery. These natural substances have shown promise in early research for reducing lesion size and stopping disease progression, but the study will confirm how well they actually work.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the Coenzyme Q10 gel or the Curcumin gel, which you will apply to your mouth lesions as instructed. The study will track your lesions and measure changes over time, likely through clinical visits and possibly saliva samples to check for chemical markers of improvement. You'll need to return for follow-up appointments and avoid other antioxidant supplements during the study.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Egypt
Sponsor
Alexandria University
Enrollment target
~34 participants
Started
November 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tasnim Saleem, BDS
Alexandria University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.